Zaks Tal Zvi 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Nov 7, 2022
Insider Transaction Report
Form 4
Zaks Tal Zvi
Director
Transactions
- Exercise/Conversion
Ordinary Shares
[F1][F2]2022-11-04+12,205→ 12,222 total - Exercise/Conversion
Restricted Share Units
[F2][F3][F1]2022-11-04−12,205→ 0 total→ Ordinary Shares (12,205 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on November 4, 2021 and vested on November 4, 2022.
Signature
/s/ Dov Bergwerk as attorney-in-fact for Tal Zvi Zaks|2022-07-11